Cannabis use and psychotic disorders: an update

References

• Hall WD. Cannabis use and psychosis. Drug Alcohol Rev 1998; 17: 433–44.
   Google Scholar
• Degenhardt L, Hall WD. The association between psycho- sis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Wellbeing. Psychol Med 2001; 31: 659–68.
   Google Scholar
• Thornicroft G. Cannabis and psychosis: is there epidemio- logical evidence for association? Br J Psychiatry 1990; 157: 25–33.
   Google Scholar
• Pinikahana J, Happell B, Keks NA. Suicide and schizo- phrenia: a review of literature for the decade (1990 – 1999) and implications for mental health nursing. Issues Mental Health Nurs 2003; 24: 27–43.
   Google Scholar
• Hall WD. A simplified logic of causal inference. Aust NZ J Psychiatry 1987; 21: 507–13.
   Google Scholar
• Bernhardson G, Gunne LM. Forty-six cases of psychosis in cannabis abusers. Int J Addict 1972; 7: 9–16.
   Google Scholar
• Chopra GS, Smith JW. Psychotic reactions following cannabis use in East Indians. Arch Gen Psychiatry 1974; 30: 24–7.
   Google Scholar
• Solomons K, Neppe VM, Kuyl JM. Toxic cannabis psychosis is a valid entity. S Afr Med J 1990; 78: 476–81.
   Google Scholar
• Wylie AS, Scott RTA, Burnett SJ. Psychosis due to ‘skunk’Br Med J 1995;311:125.
   Google Scholar
• Harding T, Knight F. Marihuana-modified mania. Arch Gen Psychiatry 1973; 29: 635–7.
   Google Scholar
• Eva J. Cannabis psychosis. Psychiatr Bull 1992; 16: 310–11.
   Google Scholar
• Carney M, Bacelle L, Robinson B. Psychosis after cannabis use. Br Med J 1984;288:1047.
   PubMed Web of Science ®Google Scholar
• Gruber AJ, Pope HG. Cannabis psychotic disorder: does it exist? Am J Addict 1994; 3: 72–83.
   Google Scholar
• Thacore VR, Shukla SR. Cannabis psychosis and paranoid schizophrenia. Arch Gen Psychiatry 1976; 3: 383–6.
   Google Scholar
• Rottanburg D, Robins AH, Ben-Arie O, Teggin A, Elk R. Cannabis-associated psychosis with hypomanic features. Lancet 1982; 2: 1364–6.
   Google Scholar
• Imade AT, Ebie JC. A retrospective study of symptom patterns of cannabis-induced psychosis. Acta Psychiatr Scand 1991; 83: 134–6.
   Google Scholar
• McGuire PK, Jones P, Harvey I, et al. Cannabis and acute psychosis. Schizophr Res 1994; 13: 161–7.
   Google Scholar
• McGuire PK, Jones P, Harvey I, Williams M, McGuffin P, Murray RM. Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophr Res 1995; 15: 277–81.
   PubMed Web of Science ®Google Scholar
• Nunez LA, Gurpegui M. Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia. Acta Psychiatr Scand 2002; 05: 173 – 8.
   Google Scholar
• Tien AY, Anthony JC. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. J Nerv Ment Dis 1990;178:473 – 80.
   Google Scholar
• Thomas H. A community survey of adverse effects of cannabis use. Drug Alcohol Depend 1996; 42: 201–7.
   Google Scholar
• Schneier FR, Siris SG. A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. J Nerv Ment Dis 1987;175:641 – 52.
   Web of Science ®Google Scholar
• Smith J, Hucker S. Schizophrenia and substance abuse. Br J Psychiatry 1994; 65: 13–21.
   Google Scholar
• Warner R, Taylor D, Wright J, et al. Substance use among the mentally ill: prevalence, reasons for use, and effects on illness. Am J Orthopsychiatry 1994; 64: 30–9.
   Google Scholar
• Mueser KT, Bellack AS, Blanchard JJ. Comorbidity of schizophrenia and substance abuse: implications for treat- ment. J Consult Clin Psychol 1992; 60: 845–56.
   Google Scholar
• Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biol Psychiatry 1996; 40: 1155–63.
   Google Scholar
• Donnelly N, Hall W, Christie P. The effects of partial decriminalisation on cannabis use in South Australia, 1985 to 1993. Aust J Publ Health 1995; 19: 281–7.
   Google Scholar
• Dixon L, Haas G, Weiden P, et al. Acute effects of drug abuse in schizophrenic patients: clinical observations and patients’ self-reports. Schizophr Bull 1990; 16: 69–79.
   Google Scholar
• Arndt S, Tyrrell G, Flaum M, Andreasen NC. Comorbidity of substance abuse and schizophrenia: the role of premorbid adjustment. Psychol Med 1992; 22: 379–88.
   Google Scholar
• Zisook S, Heaton R, Moranville J, Kuck J, Jernigan T, Braff D. Past substance abuse and clinical course of schizophre- nia. Am J Psychiatry 1992; 149: 552–3.
   Google Scholar
• Cuffel BJ, Heithoff KA, Lawson W. Correlates of patterns of substance abuse among patients with schizophrenia. Hosp Commun Psychiatry 1993; 44: 247–51.
   Google Scholar
• Kovasznay B, Bromet E, Schwartz JE, Ram R, Lavelle J, Brandon L. Substance abuse and onset of psychotic illness. Hosp Commun Psychiatry 1993; 44: 567–71.
   Google Scholar
• Phillips LJ, Curry C, Yung AR, Yuen HP, Adlard S, McGorry PD. Cannabis use is not associated with the development of psychosis in an ‘ultra’ high-risk group. Aust NZ J Psychiatry 2002; 36: 800–6.
   Google Scholar
• Anthony JC, Helzer JE. Syndromes of drug abuse and dependence. In: Robins LN, Regier DA, eds. Psychiatric disorders in America: the Epidemiological Catchment Area study. New York: Free Press, 1991.
   Google Scholar
• Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990; 264: 2511–18.
   Google Scholar
• Helzer JE, Burnam A, McEvoy LT. Alcohol abuse and dependence. In: Robins LN, Regier DA, eds. Psychiatric disorders in America: the epidemiologic catchment area study. New York, NY: Free Press, 1991.
   Google Scholar
• Bland RC, Newman SC, Orn H. Schizophrenia: lifetime comorbidity in a community sample. Acta Psychiatr Scand 1987; 75: 383–91.
   Google Scholar
• Allebeck P. Cannabis and schizophrenia: is there a causal association? In: Nahas GG, Latour, C, eds. Physiopathology of illicit drugs: cannabis, cocaine, opiates. Oxford: Perga- mon Press, 1991: 23–31.
   Google Scholar
• Bromet EJ, Dew MA, Eaton W. Epidemiology of psychosis with special reference to schizophrenia. In: Tsuang MT, Tohen M, Zahner GEP, eds. Textbook of psychiatric epidemiology. New York: Wiley-Liss, 1995: 283–300.
   Google Scholar
• Andreasson S, Engstrom A, Allebeck, ??, Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987; 2: 1483–6.
   Google Scholar
• Negrete JC. Cannabis and schizophrenia. Br J Addict 1989; 4: 349–51.
   Google Scholar
• Kandel, ??, Faust R. Sequence and stages in patterns of adolescent drug use. Arch Gen Psychiatry 1975; 32: 923–32.
   Google Scholar
• Bell DS. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 1973; 29: 35–40.
   Google Scholar
• Inghe G. The present state of abuse and addiction to stimulant drugs in Sweden. In: Sjoqvist F, Tottie M. eds. Abuse of central stimulants. New York: Raven Press, 1969: 19–27.
   Google Scholar
• Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Br Med J 2002; 325: 1199–201.
   Google Scholar
• Van Os J, Bak M, Hanssen M, Bijl RV, De Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002; 156: 319–27.
   Google Scholar
• Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Br Med J 2002;325: 1212– 13.
   Google Scholar
• Fergusson DM, Horwood JL, Swain-Campbell NR. Can- nabis dependence and psychotic symptoms in young people. Psychol Med 2003; 33: 15–21.
   Google Scholar
• Verdoux H, Gindre C, Sorbara F, Tournier M, Swendsen J. Cannabis use and the expression of psychosis vulnerability in daily life. Eur Psychiatry 2002; 17:S180– 80.
   Google Scholar
• Weil AT. Adverse reactions to marihuana: classification and suggested treatment. N Engl J Med 1970; 282: 997–1000.
   Google Scholar
• Bowers MB, Mazure CM, Nelson JC, Jatlow PI. Psychoto- genic drug use and neuroleptic response. Schizophr Bull 1990; 16: 81–5.
   Google Scholar
• Turner WM, Tsuang MT. Impact of substance abuse on the course and outcome of schizophrenia. Schizophr Bull 1990; 16: 87–95.
   Google Scholar
• Negrete JC, Knapp WP, Douglas DE, Smith WB. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol Med 1986; 16: 515–20.
   Google Scholar
• Cleghorn JM, Kaplan RD, Szechtman B, Szechtman H, Brown GM, Franco S. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. J Clin Psychiatry 1991; 52: 26–30.
   Google Scholar
• Jablensky A, Sartorius N, Ernberg G. Schizophrenia: manifestations, incidence and course in different cultures, a World Health Organization 10-country study. Psychol Med Monogr 1992;Suppl.:20.
   Google Scholar
• Martinez-Arevalo MJ, Calcedo-Ordonez A, Varo-Prieto JR. Cannabis consumption as a prognostic factor in schizo- phrenia. Br J Psychiatry 1994; 164: 679–81.
   Google Scholar
• Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994; 51: 273–9.
   Google Scholar
• Heather N, Tebbutt J. Definitions of non-abstinent and abstinent categories in alcoholism treatment outcome classifications: a review and proposal. Drug Alcohol Depend 1989; 24: 83–93.
   Google Scholar
• Kavanagh DJ. An intervention for substance abuse in schizophrenia. Behav Change 1995; 12: 20–30.
   Google Scholar
• Lehman AF, Herron JD, Schwartz RP, Myers CP. Rehabilitation for adults with severe mental illness and substance use disorders: a clinical trial. J Nerv Ment Dis 1993;181:86 – 90.
   Web of Science ®Google Scholar
• Jeffery DP, Ley A, McLaren S, Siegfried N. Psychosocial treatment programmes for people with both severe mental illness and substance misuse (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
   Google Scholar
• Jerrell JM, Ridgely MS. Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. J Nerv Ment Dis 1995;183:566 – 76.
   PubMedGoogle Scholar
• Blanchard JJ, Brown SA., Horan WP, Sherwood AR. Substance use disorders in schizophrenia: review, integra- tion, and a proposed model. Clin Psychol Rev 2002;20: 07– 34.
   Google Scholar
• Noordsy DL, Drake RE, Teague GB, et al. Subjective experiences related to alcohol use among schizophrenics. J Nerv Ment Dis 1991;179:410 – 14.
   Web of Science ®Google Scholar
• Peralta V, Cuesta MJ. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr Scand 1992; 85: 27–30.
   Google Scholar
• Hamera E, Schneider JK, Deviney S. Alcohol, cannabis, nicotine and caffeine use and symptom distress in schizo- phrenia. J Nerv Ment Dis 1995;183:559 – 65.
   PubMedGoogle Scholar
• Cohen S. Marijuana research selected recent findings. Drug Abuse Alcohol Newslett 1986; 15: 1–3.
   Google Scholar
• Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 2001; 178: 101–6.
   Google Scholar
• Drummond C. Cannabis control: costs outweigh the benefits. Against 2002; 324: 107–8.
   Google Scholar
• Hall W, Swift W. The THC content of cannabis in Australia: evidence and policy implications. Aust NZ J Publ Health 2000; 24: 503–8.
   Google Scholar
• ElSohly MA, Ross SA. Quarterly report: potency monitor- ing project 69: January 1, 1999 – March 31, 1999. NIDA contract no. N01DA-4-7404. Mississippi: National Centre for Development of Natural products, University of Mis- sissippi, 1999.
   Google Scholar
• ElSohly MA, Ross SA, Mehmedic Z, et al. Potency trends of D9-THC and other cannabinoids in confiscated marijuana from 1980 – 1997. J Forensic Sci 2000; 45: 24–30.
   Google Scholar
• Degenhardt L, Lynskey M, Hall W. Cohort trends in the age of initiation of drug use in Australia. Aust NZ J Publ Health 2000; 24: 421–6.
   Google Scholar
• Johnson RA, Gerstein D. Initiation of use of alcohol, cigarettes, marijuana, cocaine and other substances in US birth cohorts since 1919. Am J Publ Health 1998; 8: 27–33.
   Google Scholar
• Hall W, Pacula RL. Cannabis use and dependence: policy health and the public policy. Cambridge: Cambridge University Press, 2003.
   Google Scholar
• Poole R, Brabbins G. Drug induced psychosis. Br J Psychiatry 1996; 68: 135–8.
   Google Scholar
• Stahl SM, Muntner N. Essential psychopharmacology: neuroscientific basis and clinical applications. Cambridge: Cambridge University Press, 1996.
   Google Scholar
• Moore H, West AR, Grace AA. The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biol Psychiatry 1999; 46: 40–55.
   Google Scholar
• Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 1997; 276: 2048–50.
   Google Scholar
• Gottesman II. Schizophrenia genesis: the origins of mad- ness. New York: W. Freeman, 1991.
   Google Scholar
• Der G, Gupta S, Murray RM. Is schizophrenia disappear- ing? Lancet 1990; 335: 513–16.
   Google Scholar
• Degenhardt L, Hall W, Lynskey M. Testing hypotheses about relationships between cannabis use and psychosis in Australia. Drug Alcohol Depend 2003; 71: 37–48.
   Google Scholar
• Donnelly N, Hall W. Patterns of cannabis use in Australia. NCADA (NDS) monograph series No.27. Canberra: AGPS, 1994. Available at: 5 url: http:// www.health.go- v.au/pubhlth/publicat/ 4
   Google Scholar
• Kendell RE, Malcolm DE, Adams W. The problem of detecting changes in the incidence of schizophrenia. Br J Psychiatry 1993; 162: 212–18.
   Google Scholar
• Joyce PR. Changing trends in first admissions and read- missions for mania and schizophrenia in New Zealand, 1974 to 1984. Aust NZ J Psychiatry 1987; 21: 82–6.
   Google Scholar
• Jablensky A. Schizophrenia: epidemiology. Curr Opin Psychiatry 1999; 12: 19–28.
   Google Scholar